Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group

Completed

Looking for future studies?

Key information

Conditions

Cystic Fibrosis Congenital, Hereditary, and Neonatal Diseases and Abnormalities Digestive System Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Lung Diseases Pancreatic Diseases Respiratory Tract Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Ghent

Ghent, 9000, Belgium

About this study

Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of cystic fibrosis

Exclusion criteria

Treatment and study plan

Blood sampling for determination of serum Zn

Procedure

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Collaborators

Scientific research fund Bruges

Registry information

Important dates

Study start: 2004
First posted: Sep 22, 2005
Registry last updated: Jul 7, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed